-
- Pronounced: ee-VIS-tuh
- Mechanism of action: SERMs mimic estrogen's effects on bone, which reduces bone resorption and increases bone formation.
- Common side effects: Hot flashes, sweating, leg cramps, blood clots, weight gain, depression, insomnia
- Clinical trials: STAR Trial showed Evista (Raloxifene) was as effective at preventing breast cancer as Tamoxifen, but with a reduced risk of cataracts or DVTs.
- News: September 14, 2007, the FDA approved Evista (Raloxifene) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis.
-
-
Evista (Raloxifene) is a selective estrogen receptor modulator (SERM) used in the prevention and treatment of osteoporosis.
-
-
-
Evista (Raloxifene) on Amazon
-
Evista (raloxifene):: A Medical Doctor Answers All Your Questions About The New F.d.a. Approved "miracle" Drug For Women - $5.99
While hormone replacement therapy is often recommended to protect menopausal and postmenopausal women from osteoporosis, heart didease, and menopausal symptoms, hormone therapy may...Amazon
-
Head-to-head comparison of osteoporosis drugs: alendronate vs. raloxifene.(Women's Health): An article from: Family Practice News - $5.95
This digital document is an article from Family Practice News, published by International Medical News Group on August 1, 2003. The length of the article is 484 words. The page len...Amazon
-
Raloxifene Causes No Increase in CV Events in Women.(Brief Article): An article from: Family Practice News - $5.95
This digital document is an article from Family Practice News, published by International Medical News Group on May 1, 2001. The length of the article is 2295 words. The page lengt...Amazon
-
-
On Twitter Powered by Twitter
-
Ladies, Pick Your Cancer: SERMs, like tamoxifen and Evista (raloxifene), could help mammogram readability and e.. http://bit.ly/7QFiAc
-
About this page
-
Page Views0
No one is currently managing this page.
If you would like to apply
to be the manager of this page, please request below.
If you would like to apply
to be the manager of this page, please request below.
This page currently has no vertical manager.
